Koornstra, Rutger H.T.
https://orcid.org/0000-0002-5446-755X
Mayo Clinic
UMC St Radboud, Nijmegen, Netherlands;
Citations 1
53BP1 as a predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancer.
Hurley, Rachel M. , Hendrickson, Andrea E. Wahner , Visscher, Daniel W., Ansell, Peter , Harrell, Maria I., Wagner, Jill M., Negron, Vivian , Goergen, Krista M., Oberg, Ann L. , Jonge, Maja J. De, Herpen, Carla M.L. van , Koornstra, Rutger H.T. , Jager, Agnes , Hollander, Martha W. den, Dudley, Matthew W., Shepherd, Stacie Peacock, Maurer, Matthew J. , Gietema, Jourik A. , Swisher, Elizabeth M. , Kaufmann, Scott H.
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 5538-5538
